Cargando…

Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis

Therapeutic management and research in Amyotrophic Laterals Sclerosis (ALS) have been limited by the substantial heterogeneity in progression and anatomical spread that are endemic of the disease. Neuroimaging biomarkers represent powerful additions to the current monitoring repertoire but have yiel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steinbach, Robert, Batyrbekova, Meerim, Gaur, Nayana, Voss, Annika, Stubendorff, Beatrice, Mayer, Thomas E., Gaser, Christian, Witte, Otto W., Prell, Tino, Grosskreutz, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940701/ https://www.ncbi.nlm.nih.gov/pubmed/31896467 http://dx.doi.org/10.1016/j.nicl.2019.102094

Ejemplares similares

Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model
por: Steinbach, Robert, et al.
Publicado: (2020)

Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model
por: Steinbach, Robert, et al.
Publicado: (2020)

Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2021)

Blood–Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis
por: Prell, Tino, et al.
Publicado: (2021)

Developing a Neuroimaging Biomarker for Amyotrophic Lateral Sclerosis: Multi-Center Data Sharing and the Road to a “Global Cohort”
por: Steinbach, Robert, et al.
Publicado: (2018)

Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model
por: Dreger, Marie, et al.
Publicado: (2021)

Reaction to Endoplasmic Reticulum Stress via ATF6 in Amyotrophic Lateral Sclerosis Deteriorates With Aging
por: Prell, Tino, et al.
Publicado: (2019)

Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data
por: Prell, Tino, et al.
Publicado: (2020)

Monocyte-Derived Macrophages Contribute to Chitinase Dysregulation in Amyotrophic Lateral Sclerosis: A Pilot Study
por: Gaur, Nayana, et al.
Publicado: (2021)

Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis
por: Prell, Tino, et al.
Publicado: (2019)

Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?
por: Prell, Tino, et al.
Publicado: (2016)

Voxel-Based MRI Intensitometry Reveals Extent of Cerebral White Matter Pathology in Amyotrophic Lateral Sclerosis
por: Hartung, Viktor, et al.
Publicado: (2014)

Motor unit number index (MUNIX) loss of 50% occurs in half the time of 50% functional loss according to the D50 disease progression model of ALS
por: Ebersbach, Theresa, et al.
Publicado: (2023)

The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond
por: Gaur, Nayana, et al.
Publicado: (2020)

Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness
por: Dieckmann, Nora, et al.
Publicado: (2022)

Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients
por: Perner, Caroline, et al.
Publicado: (2018)

Use of vitamins by participants in amyotrophic lateral sclerosis clinical trials
por: Prell, Tino, et al.
Publicado: (2020)

Motor unit number index (MUNIX) in the D50 disease progression model reflects disease accumulation independently of disease aggressiveness in ALS
por: Ebersbach, Theresa, et al.
Publicado: (2022)

Plasma VCAM1 levels correlate with disease severity in Parkinson’s disease
por: Perner, Caroline, et al.
Publicado: (2019)

Susceptibility-Weighted Imaging Provides Insight into White Matter Damage in Amyotrophic Lateral Sclerosis
por: Prell, Tino, et al.
Publicado: (2015)

Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease
por: Prell, Tino, et al.
Publicado: (2019)

The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis
por: Tadic, Vedrana, et al.
Publicado: (2014)

Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis
por: Keil, Carsten, et al.
Publicado: (2012)

Association between malnutrition, clinical parameters and health-related quality of life in elderly hospitalized patients with Parkinson’s disease: A cross-sectional study
por: Gruber, Maria Theresa, et al.
Publicado: (2020)

Data on adherence to medication in neurological patients using the German Stendal Adherence to Medication Score (SAMS)
por: Prell, Tino, et al.
Publicado: (2019)

Sicca Symptoms in Parkinson's Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life
por: Prell, Tino, et al.
Publicado: (2020)

What Predicts Different Kinds of Nonadherent Behavior in Elderly People With Parkinson's Disease?
por: Mendorf, Sarah, et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
por: Dreger, Marie, et al.
Publicado: (2022)

Impact of subthreshold depression on health-related quality of life in patients with Parkinson’s disease based on cognitive status
por: Schönenberg, Aline, et al.
Publicado: (2021)

Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease
por: Prell, Tino, et al.
Publicado: (2019)

Classification of amyotrophic lateral sclerosis by brain volume, connectivity, and network dynamics
por: Thome, Janine, et al.
Publicado: (2021)

DNA strand breaks and TDP-43 mislocation are absent in the murine hSOD1(G93A) model of amyotrophic lateral sclerosis in vivo and in vitro
por: Penndorf, Diane, et al.
Publicado: (2017)

Distinct patterns of progressive gray and white matter degeneration in amyotrophic lateral sclerosis
por: Ishaque, Abdullah, et al.
Publicado: (2021)

Ultrasonography of the Vagus Nerve in Parkinson's Disease
por: Fedtke, Nadin, et al.
Publicado: (2018)

Amyotrophic Lateral Sclerosis: Advances and Prospects
por: Boentert, Matthias, et al.
Publicado: (2023)

Association between different coping styles and health-related quality of life in people with Parkinson’s disease: a cross-sectional study
por: Liebermann, Jenny Doris, et al.
Publicado: (2020)

Current and Desired Quality of Life in People with Parkinson’s Disease: The Calman Gap Increases with Depression
por: Prell, Tino, et al.
Publicado: (2020)

Association Between Nonmotor Symptoms and Nonadherence to Medication in Parkinson's Disease
por: Mendorf, Sarah, et al.
Publicado: (2020)

Age-dependent increase of cytoskeletal components in sensory axons in human skin
por: Metzner, Klara, et al.
Publicado: (2022)

Changes in Gray Matter Induced by Learning—Revisited
por: Driemeyer, Joenna, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_lkt9118usuvv7092hs6erc1miq